about
Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of VareniclineOxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literatureAbsorption Kinetics of Subcutaneously Administered Ceftazidime in Hypoperfused Guinea Pigs.Identification of the Discrepancies between Pharmacist and Patient Perception of the Pharmacist's Role as an Advisor on Drug Therapy Based on Social Science Theory.Quantitative evaluation of initial symptoms as predictors to detect adverse drug reactions using Bayes' theory: expansion and evaluation of drug-adverse drug reaction-initial symptom combinations using adverse event reporting system database.A survey of subcutaneous blood flow in patients with SMID and subcutaneous ceftazidime administration using mentholated warm compresses in healthy subjects.The inhibitory effect of kakkonto, Japanese traditional (kampo) medicine, on brain penetration of oseltamivir carboxylate in mice with reduced blood-brain barrier function.High-Resolution Magic-Angle Spinning-1H-NMR Spectroscopy-Based Metabolic Profiling of Hippocampal Tissue in Rats with Depression-Like Symptoms.Discrepancies between patients' and pharmacists' perceptions of the role of community pharmacists as advisors on the use of pharmaceuticals in Japan: A comparison prior to and following revision of the Pharmacists' ActThe use of an artificial skin model to study transdermal absorption of drugs in inflamed skinPoly-L-arginine-Induced internalization of tight junction proteins increases the paracellular permeability of the Caco-2 cell monolayer to hydrophilic macromoleculesEffect of Physiological Changes in the Skin on Systemic Absorption of Tacrolimus Following Topical Application in Rats
P50
Q28554297-89E442A0-1919-4855-AF9F-4CD342749A7DQ33402268-67E0DFF0-576D-464A-B74D-C7F14B6AA7A3Q36278247-27FC719C-2F73-4A3A-B616-D92E70E440C8Q38928451-4D1A028C-2958-46D2-8428-688BEC9505CAQ40226482-98A6C214-FD6A-475C-B0EF-A195D9DA6309Q40778573-D345C7B1-AED9-4155-BDCE-1D73407C837EQ41411223-F2EF617E-BD14-4CF6-90FD-C0FD48CE70C8Q47954885-62B76012-6B7A-4F48-8DA7-6ED0DA20B6FDQ64067781-A3E9A970-B8BA-4F88-BE72-A2C339DAB8C2Q83369146-94C0E57C-D797-4974-BE37-31CDBBFD6D15Q85755639-A0F5195A-BAB8-40EF-B196-1F96B44F3E91Q87401665-723C4A92-29AD-4F2F-A86D-45CA92E5A7FE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Shinji Oshima
@en
Shinji Oshima
@nl
type
label
Shinji Oshima
@en
Shinji Oshima
@nl
prefLabel
Shinji Oshima
@en
Shinji Oshima
@nl
P108
P31
P496
0000-0003-2638-0550